Bryan Weingarten has played a meaningful role in strengthening the Genetics and Personalized Cancer Prevention Program at Weill Cornell Medicine, helping advance a model of care that blends medical innovation with compassionate, patient-centered support. His commitment reflects a deep belief in empowering individuals and families with the knowledge and resources needed to understand and manage their cancer risk.
The program has already served more than 500 patients, a testament to both its growing reach and the foundational support that makes this level of care possible. Bryan’s involvement has helped expand the program’s multidisciplinary approach, ensuring patients receive comprehensive guidance that addresses prevention, education, and long-term care in a truly personalized way.
One of the most significant outcomes of Bryan’s support is the program’s ability to integrate dedicated psychosocial care into its prevention model. His gift made possible the addition of Emily Epstein, LMSW, a full-time clinical social worker who supports patients and families navigating hereditary cancer risk. Through her work and leadership of family outreach initiatives, Emily helps ensure that care extends beyond the individual patient to reach at-risk relatives who may benefit from genetic education and testing.
Beyond philanthropy, Bryan remains actively engaged with the program and its mission. He regularly attends educational events and discussions hosted by Weill Cornell Medicine, including recent Cancer Prevention and Genetics conversations. His presence reinforces a shared goal of empowering individuals through education, prevention, and personalized care.
As Dr. Melissa Frey, MD, Director of the Genetics and Personalized Cancer Prevention Program, has shared, the program’s continued progress reflects the confidence and generosity of supporters like Bryan. His investment is helping build a lasting framework for cancer prevention that prioritizes both scientific excellence and meaningful human impact.
Related Posts
